Skip to main content
Clinical Trials/JPRN-UMIN000022879
JPRN-UMIN000022879
Completed
未知

Interventional study for severe obesity patients with non-alcoholic fatty liver disease (NAFLD) by Mazindol - Interventional study for severe obesity with NAFLD by Mazindol

Gunma University Hospital0 sites20 target enrollmentJuly 1, 2016

Overview

Phase
未知
Intervention
Not specified
Conditions
Severe obesity patient with non-alcoholic fatty liver disease
Sponsor
Gunma University Hospital
Enrollment
20
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 1, 2016
End Date
March 31, 2018
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Allergy to Mazindol, Glaucoma, Severe heart disease, Severe diabetes mellitus, Severe liver and renal disturbance, Severe hypertension, Cerebrovascular disease, Mental illness, Seizure, Alcohol and drug abuse, MAO inhibitor, Pregnant woman

Outcomes

Primary Outcomes

Not specified

Similar Trials